Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Mohammed Orloff

Concepts (238)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Genetic Predisposition to Disease
12
2025
507
1.250
 Why?
Germ-Line Mutation
9
2013
61
1.030
 Why?
Hamartoma Syndrome, Multiple
8
2012
14
1.030
 Why?
PTEN Phosphohydrolase
13
2015
53
1.000
 Why?
Barrett Esophagus
2
2019
30
0.980
 Why?
Esophageal Neoplasms
2
2019
105
0.900
 Why?
Adenocarcinoma
3
2019
396
0.810
 Why?
Haplotypes
3
2020
83
0.750
 Why?
Polymorphism, Single Nucleotide
9
2021
468
0.650
 Why?
Homozygote
3
2019
57
0.640
 Why?
Carcinoma, Non-Small-Cell Lung
1
2020
153
0.610
 Why?
Proto-Oncogene Proteins c-akt
4
2012
155
0.570
 Why?
Databases, Factual
1
2020
676
0.540
 Why?
Alleles
6
2021
252
0.440
 Why?
Lung Neoplasms
3
2020
597
0.440
 Why?
Phosphatidylinositol 3-Kinases
2
2012
139
0.400
 Why?
Genotype
6
2021
525
0.390
 Why?
Scavenger Receptors, Class A
1
2011
39
0.360
 Why?
Extracellular Matrix Proteins
1
2011
66
0.360
 Why?
Case-Control Studies
5
2025
1152
0.300
 Why?
Genetic Variation
3
2021
197
0.290
 Why?
Humans
38
2025
50419
0.290
 Why?
Transcription Factors
1
2011
561
0.280
 Why?
Breast Neoplasms
7
2017
1198
0.280
 Why?
Thyroid Neoplasms
4
2012
109
0.270
 Why?
Heart Defects, Congenital
2
2024
603
0.270
 Why?
Limb Deformities, Congenital
1
2025
14
0.240
 Why?
Genes, Wilms Tumor
1
2005
1
0.240
 Why?
Population
1
2005
9
0.240
 Why?
Gene Frequency
3
2020
93
0.240
 Why?
Glomerulosclerosis, Focal Segmental
1
2005
13
0.240
 Why?
Genome
2
2019
57
0.230
 Why?
Lamin Type A
1
2024
6
0.230
 Why?
Female
22
2025
27053
0.220
 Why?
Capacity Building
1
2024
18
0.220
 Why?
Exome
2
2025
48
0.220
 Why?
DNA Methylation
3
2024
548
0.220
 Why?
Adult
16
2024
13561
0.210
 Why?
Middle Aged
16
2021
12579
0.210
 Why?
Linkage Disequilibrium
2
2020
35
0.210
 Why?
Smoke-Free Policy
1
2022
9
0.200
 Why?
Tobacco Smoke Pollution
1
2022
48
0.190
 Why?
Male
16
2025
25866
0.190
 Why?
Inheritance Patterns
1
2021
22
0.180
 Why?
Phenotype
7
2021
736
0.180
 Why?
Models, Genetic
5
2013
166
0.180
 Why?
Risk Factors
5
2019
3712
0.170
 Why?
Stilbenes
2
2010
52
0.170
 Why?
Succinate Dehydrogenase
2
2011
22
0.170
 Why?
Aged
11
2020
9738
0.170
 Why?
Fires
1
2020
14
0.170
 Why?
Agriculture
1
2020
19
0.160
 Why?
Tobacco Products
1
2021
124
0.160
 Why?
Social Media
1
2021
99
0.160
 Why?
Cluster Analysis
4
2013
209
0.160
 Why?
Aged, 80 and over
5
2020
3233
0.160
 Why?
Genomics
1
2020
238
0.150
 Why?
Cell Proliferation
3
2010
980
0.150
 Why?
Pulmonary Disease, Chronic Obstructive
1
2020
136
0.140
 Why?
Prostatic Neoplasms
2
2012
386
0.140
 Why?
Gene Expression Regulation, Neoplastic
3
2010
831
0.140
 Why?
Prognosis
2
2020
1974
0.140
 Why?
Endometrial Neoplasms
2
2015
137
0.130
 Why?
Leprosy
1
2016
5
0.130
 Why?
Hypertension
1
2021
545
0.130
 Why?
Emergency Service, Hospital
1
2020
489
0.120
 Why?
Asthma
1
2020
303
0.120
 Why?
Microsatellite Repeats
2
2012
37
0.120
 Why?
Regression Analysis
2
2017
376
0.120
 Why?
Aromatase
1
2015
8
0.120
 Why?
Tuberculosis
1
2016
131
0.120
 Why?
Arkansas
4
2024
1974
0.120
 Why?
Genetic Linkage
2
2011
26
0.110
 Why?
Young Adult
7
2021
4075
0.110
 Why?
Adolescent
8
2021
6453
0.110
 Why?
Sirolimus
2
2010
61
0.110
 Why?
Genome-Wide Association Study
2
2012
163
0.100
 Why?
Bone Morphogenetic Protein Receptors, Type I
1
2013
1
0.100
 Why?
Smad4 Protein
1
2013
5
0.100
 Why?
Genetic Testing
2
2010
120
0.100
 Why?
Cohort Studies
3
2012
1451
0.100
 Why?
Class I Phosphatidylinositol 3-Kinases
1
2012
17
0.100
 Why?
Colonic Polyps
1
2013
37
0.100
 Why?
Receptors, Cell Surface
1
2013
117
0.100
 Why?
Mitochondrial Diseases
1
2012
41
0.100
 Why?
Codon, Nonsense
1
2012
26
0.100
 Why?
Flavin-Adenine Dinucleotide
1
2011
4
0.090
 Why?
Antigens, CD
1
2013
221
0.090
 Why?
NAD
1
2011
41
0.090
 Why?
Genes, p53
1
2011
49
0.090
 Why?
DNA, Neoplasm
1
2012
144
0.090
 Why?
Siblings
1
2011
32
0.090
 Why?
Gene Expression Profiling
3
2012
1020
0.090
 Why?
Mutation, Missense
1
2012
103
0.090
 Why?
Taxoids
1
2011
37
0.090
 Why?
Adenoma
1
2012
113
0.090
 Why?
Risk
1
2012
325
0.090
 Why?
Software
1
2013
268
0.090
 Why?
Colorectal Neoplasms
2
2012
256
0.090
 Why?
Intestinal Polyps
1
2010
7
0.090
 Why?
Receptors, Androgen
1
2010
45
0.090
 Why?
Cephalometry
1
2010
18
0.080
 Why?
Tumor Microenvironment
1
2012
221
0.080
 Why?
Gene Dosage
1
2009
73
0.080
 Why?
Head
1
2010
72
0.080
 Why?
Carcinoma, Transitional Cell
1
2010
51
0.080
 Why?
Intracellular Signaling Peptides and Proteins
1
2010
134
0.080
 Why?
Patient Selection
1
2010
257
0.080
 Why?
Cell Communication
1
2009
70
0.080
 Why?
Drug Resistance, Neoplasm
1
2011
315
0.080
 Why?
Age Factors
1
2012
1118
0.080
 Why?
Urinary Bladder Neoplasms
1
2010
158
0.080
 Why?
Immunohistochemistry
1
2011
955
0.070
 Why?
Smoking
1
2012
506
0.070
 Why?
Prevalence
2
2021
967
0.070
 Why?
Chromosome Mapping
2
2021
143
0.070
 Why?
Prospective Studies
4
2017
2378
0.070
 Why?
Mass Screening
1
2010
343
0.070
 Why?
Rural Population
2
2022
556
0.070
 Why?
Cell Line, Tumor
4
2011
1393
0.070
 Why?
Physical Chromosome Mapping
1
2005
8
0.060
 Why?
Multiple Myeloma
1
2020
2990
0.060
 Why?
Antineoplastic Agents
2
2011
1165
0.060
 Why?
Frasier Syndrome
1
2005
1
0.060
 Why?
Denys-Drash Syndrome
1
2005
3
0.060
 Why?
DNA Copy Number Variations
1
2025
109
0.060
 Why?
Exons
1
2005
94
0.060
 Why?
Child
5
2020
6931
0.060
 Why?
CpG Islands
1
2024
107
0.060
 Why?
Models, Theoretical
1
2005
168
0.050
 Why?
Gene Expression Regulation
1
2008
948
0.050
 Why?
Mutation
2
2010
1275
0.050
 Why?
Biopsy
1
2005
588
0.050
 Why?
Polyproteins
1
2022
2
0.050
 Why?
Child, Preschool
3
2020
3953
0.050
 Why?
RNA, Viral
1
2022
107
0.050
 Why?
Risk Assessment
2
2021
1268
0.050
 Why?
Phosphoproteins
1
2022
116
0.050
 Why?
Cardiomyopathy, Hypertrophic, Familial
1
2021
5
0.050
 Why?
United States Food and Drug Administration
1
2021
91
0.040
 Why?
Membrane Glycoproteins
1
2022
246
0.040
 Why?
Azacitidine
1
2020
34
0.040
 Why?
Nutrition Surveys
1
2021
112
0.040
 Why?
Loss of Heterozygosity
2
2012
75
0.040
 Why?
United States
2
2021
5005
0.040
 Why?
Stromal Cells
2
2012
75
0.040
 Why?
Nicotine
1
2021
184
0.040
 Why?
TOR Serine-Threonine Kinases
2
2010
76
0.040
 Why?
Self Report
1
2021
206
0.040
 Why?
Pedigree
2
2010
119
0.040
 Why?
Seasons
1
2020
80
0.040
 Why?
Neoplasms
1
2009
1248
0.040
 Why?
Signal Transduction
3
2010
1608
0.040
 Why?
Odds Ratio
1
2021
550
0.040
 Why?
Air Pollution
1
2020
46
0.040
 Why?
Phosphorylation
2
2010
520
0.040
 Why?
Gene Expression
2
2012
605
0.040
 Why?
Sensitivity and Specificity
2
2012
855
0.040
 Why?
Predictive Value of Tests
2
2012
924
0.040
 Why?
Treatment Outcome
2
2020
5265
0.040
 Why?
Dexamethasone
1
2020
431
0.040
 Why?
Infant
2
2020
3648
0.030
 Why?
Dose-Response Relationship, Drug
2
2010
1369
0.030
 Why?
Angiopoietin-2
1
2017
15
0.030
 Why?
Angiopoietin-1
1
2017
16
0.030
 Why?
Receptor, TIE-2
1
2017
16
0.030
 Why?
Fibroblast Growth Factor 2
1
2017
35
0.030
 Why?
Clinical Trials, Phase II as Topic
1
2017
46
0.030
 Why?
Matrix Metalloproteinase 9
1
2017
88
0.030
 Why?
Vascular Endothelial Growth Factor A
1
2017
180
0.030
 Why?
Cross-Sectional Studies
1
2021
1601
0.030
 Why?
Neovascularization, Pathologic
1
2017
155
0.030
 Why?
Neoadjuvant Therapy
1
2017
119
0.030
 Why?
HapMap Project
1
2015
3
0.030
 Why?
Introns
1
2015
49
0.030
 Why?
Antineoplastic Combined Chemotherapy Protocols
1
2020
997
0.030
 Why?
Pilot Projects
1
2016
694
0.030
 Why?
Peutz-Jeghers Syndrome
1
2013
2
0.030
 Why?
Databases, Genetic
1
2013
77
0.030
 Why?
Genome, Human
1
2013
108
0.020
 Why?
Validation Studies as Topic
1
2012
10
0.020
 Why?
Penetrance
1
2012
6
0.020
 Why?
Neoplasm Grading
1
2012
122
0.020
 Why?
Genetic Association Studies
1
2012
118
0.020
 Why?
Vincristine
1
2011
82
0.020
 Why?
Anthracyclines
1
2011
29
0.020
 Why?
Inhibitory Concentration 50
1
2010
68
0.020
 Why?
Paclitaxel
1
2011
84
0.020
 Why?
Formazans
1
2010
4
0.020
 Why?
Immunoblotting
1
2010
114
0.020
 Why?
Tetrazolium Salts
1
2010
15
0.020
 Why?
Androgen Antagonists
1
2010
11
0.020
 Why?
Extracellular Signal-Regulated MAP Kinases
1
2010
80
0.020
 Why?
Drug Synergism
1
2010
149
0.020
 Why?
HEK293 Cells
1
2011
209
0.020
 Why?
Mitogen-Activated Protein Kinases
1
2010
154
0.020
 Why?
Epithelial Cells
1
2012
203
0.020
 Why?
Michigan
1
2010
19
0.020
 Why?
Point Mutation
1
2010
61
0.020
 Why?
Ribosomal Protein S6 Kinases, 70-kDa
1
2010
17
0.020
 Why?
Kidney Neoplasms
1
2012
174
0.020
 Why?
Neoplasm Transplantation
1
2010
83
0.020
 Why?
Androgens
1
2010
71
0.020
 Why?
Transplantation, Heterologous
1
2010
73
0.020
 Why?
Heredity
1
2009
2
0.020
 Why?
Adenosine Triphosphate
1
2011
230
0.020
 Why?
BRCA2 Protein
1
2009
16
0.020
 Why?
Endoscopy, Gastrointestinal
1
2010
75
0.020
 Why?
Comparative Genomic Hybridization
1
2009
36
0.020
 Why?
BRCA1 Protein
1
2009
32
0.020
 Why?
Polymerase Chain Reaction
1
2011
447
0.020
 Why?
Proteins
1
2012
340
0.020
 Why?
Mice, Nude
1
2010
247
0.020
 Why?
Chi-Square Distribution
1
2010
275
0.020
 Why?
Cell Cycle
1
2010
227
0.020
 Why?
Algorithms
1
2013
624
0.020
 Why?
Protein Binding
1
2011
648
0.020
 Why?
Gene Deletion
1
2010
260
0.020
 Why?
Diagnosis, Differential
1
2012
1029
0.020
 Why?
Cell Survival
1
2010
587
0.020
 Why?
Promoter Regions, Genetic
1
2010
455
0.020
 Why?
Incidence
1
2012
1027
0.020
 Why?
Neoplasm Invasiveness
1
2009
269
0.020
 Why?
Neoplastic Stem Cells
1
2009
97
0.020
 Why?
Membrane Proteins
1
2010
337
0.020
 Why?
Neoplasm Staging
1
2011
738
0.020
 Why?
Cell Transformation, Neoplastic
1
2009
182
0.020
 Why?
Oligonucleotide Array Sequence Analysis
1
2009
400
0.020
 Why?
Microscopy, Confocal
1
2008
84
0.020
 Why?
Cell Differentiation
1
2011
640
0.020
 Why?
Chromosome Aberrations
1
2009
279
0.020
 Why?
Survival Rate
1
2010
906
0.020
 Why?
Registries
1
2010
565
0.020
 Why?
Chromosomes, Human
1
2005
39
0.020
 Why?
Time Factors
1
2010
2933
0.010
 Why?
Reproducibility of Results
1
2005
1181
0.010
 Why?
Mice
1
2010
5659
0.010
 Why?
Animals
1
2010
13063
0.010
 Why?
Orloff's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (238) concept(s)
_
Co-Authors Expand Description
See all (27) people
_
Similar People Expand Description
See all (26) people
_
Same Department Expand Description
Search Department